Peter Heerma
CHIEF COMMERCIAL OFFICER · 2 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | May 5, 2026 | Sale | $46.65 | 2,174 | $101.4K | 140,684 | |
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | May 4, 2026 | Option Exercise | $0.00 | 4,250 | — | 142,858 | |
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | Apr 14, 2026 | Sale | $41.93 | 7,215 | $302.5K | 138,608 | |
TVTX | Peter Heerma | CHIEF COMMERCIAL OFFICER | Apr 13, 2026 | Grant/Award | $0.00 | 14,000 | — | 145,823 |